Clinical Trials Directory

Trials / Completed

CompletedNCT05536206

Continuous and Wireless Vital Sign Monitoring in Patients at Home After Acute Medical Admission

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Bispebjerg Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The current study aims to investigate the feasibility of transmitting continuous and wireless vital sign data in real time from patients home to the hospital in patients discharged after an acute medical hospitalization

Detailed description

The healthcare system is challenged by an aging patient population with chronic diseases, and acute admissions must be housed in hospitals with fewer beds and less staff resources. This increases the need for earlier discharge and for treatment shifted to the patients' own home. Furthermore, the transition from the hospital to the home setting is one of potential hazard, due to the lack of observation and intervention possibilities. This study aims to investigate the feasibility of wireless, continuous monitoring of patients in the days around discharge after an acute medical hospitalization, as well as occurrence of deviating vital signs i in the patients' own homes during the first days after discharge. Data will be transmitted continuously in real time from patient's homes to mobile applications for portable handheld devices such as healthcare personnel's smartphones.

Conditions

Interventions

TypeNameDescription
DEVICEWireless and continuously monitoringIncluded patients are monitored with WARD equipment during the last part of hospitalization and the first days after discharge with data transmitted in real time to personnel at the hospital. Monitoring will last for a maximum of 72 hours.

Timeline

Start date
2022-12-01
Primary completion
2023-07-30
Completion
2023-07-30
First posted
2022-09-10
Last updated
2023-09-28

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT05536206. Inclusion in this directory is not an endorsement.